$1.74 Billion is the total value of DOWLING & YAHNKE LLC's 367 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -11,000 | -100.0% | -0.01% | – |
| CTVA | Exit | CORTEVA INC | $0 | – | -4,300 | -100.0% | -0.01% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -6,453 | -100.0% | -0.02% | – |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $0 | – | -2,112 | -100.0% | -0.02% | – |
| IAU | Exit | ISHARES GOLD TRUSTishares | $0 | – | -17,874 | -100.0% | -0.02% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -1,390 | -100.0% | -0.02% | – |
| CRWD | Exit | CROWDSTRIKE HLDGS INCcl a | $0 | – | -1,757 | -100.0% | -0.02% | – |
| TSLX | Exit | SIXTH STREET SPECIALTY LENDN | $0 | – | -19,374 | -100.0% | -0.03% | – |
| NMFC | Exit | NEW MTN FIN CORP | $0 | – | -34,325 | -100.0% | -0.03% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -8,409 | -100.0% | -0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RELIANCE STEEL & ALUMINUM CO | 38 | Q3 2022 | 8.8% |
| Coca-Cola Company | 38 | Q3 2022 | 4.6% |
| LANCASTER COLONY CORP | 38 | Q3 2022 | 3.0% |
| Microsoft Inc. | 38 | Q3 2022 | 2.6% |
| QUALCOMM INC | 38 | Q3 2022 | 2.2% |
| Vgd Utility ETF | 38 | Q3 2022 | 1.6% |
| Vgd Materials ETF | 38 | Q3 2022 | 1.5% |
| HOME DEPOT INC | 38 | Q3 2022 | 1.3% |
| JOHNSON & JOHNSON | 38 | Q3 2022 | 1.4% |
| Walt Disney Hold Co. | 38 | Q3 2022 | 1.3% |
View DOWLING & YAHNKE LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-07-21 |
| 13F-HR | 2021-04-29 |
| 13F-HR | 2021-01-28 |
| 13F-HR | 2020-10-19 |
| 13F-HR | 2020-07-31 |
View DOWLING & YAHNKE LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.